Liver Transplantation: Indications, Contraindications and Results

Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

Volumn , Issue , 2008, Pages 1984-1995

  Everson, Gregory T ^a   Membreno, Fernando E ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b Methodist Specialty and Transplant Hospital   (United States)

Author keywords

Alcoholic liver disease; Encephalopathy; Hepatitis C virus; Thomas Starzl; United States

Indexed keywords

EID: 84889321057     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470691861.ch25b     Document Type: Chapter

References (128)

1. Transplant Patient DataSource (2005). Richmond VA: United Network for Organ Sharing. Retrieved August 8, 2005 from the World Wide Web: http://www.patients.unos.org/data.htm.
2. Trotter JF, Wachs M, Everson GT et al. (2002) Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 346, 1074-1082.
3. Adam R, McMaster P, O'Grady JG et al. (2003) Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 9, 1231-1243.
4. Murray KF, Carithers RL, Jr (2005) AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 41, 1407-1432.
5. Plotkin JS, Scott VL, Pinna A et al. (1996) Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 2, 426-430.
6. Plotkin JS, Benitez RM, Kuo PC et al. (1998) Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg 4, 253-257.
7. Lucey MR, Brown KA, Everson GT et al. (1997) Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 3, 628-637.
8. Grace ND (1997) Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 92, 1081-1091.
9. Policy. 3.6 Organ Distribution (2001). Richmond VA: United Network for Organ Sharing. Retrieved November 10, 2001 from the World Wide Web: http://www.unos.org/About/policy_policies03_06.htm.
10. Freeman RB, Jr, Edwards EB (2000) Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl 6, 543-552.
11. Institute of Medicine (1999) Analysis of waiting times. In: Committee on Organ Transplantation. Assessing Current Policies and the Potential Impact of the DHHS Final Rule. Washington DC: National Academy Press, pp. 57-78.
12. Wiesner RH, McDiarmid SV, Kamath PS et al. (2001) MELD and PELD: application of survival models to liver allocation. Liver Transpl 7, 567-580.
13. Malinchoc M, Kamath PS, Gordon FD et al. (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31, 864-871.
14. Freeman RB, Wiesner RH, Edwards E et al. (2004) Results of the first year of the new liver allocation plan. Liver Transpl 10, 7-15.
15. Kamath PS, Wiesner RH, Malinchoc M et al. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33, 464-470.
16. Freeman RB, Rohrer RJ, Katz E et al. (2001) Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time. Liver Transpl 7, 173-178.
17. Wiesner R, Edwards E, Freeman R et al. (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124, 91-96.
18. Olthoff KM, Brown RS, DelMonico FL et al. (2004) Summary Report of a National Conference: evolving concepts in liver allocation in the MELD/PELD era. Liver Transplantation 10 (SUPPL. 2), A6-A22.
19. McDiarmid SV, Merion RM, Dykstra DM et al. (2004) Selection of pediatric candidates under the PELD system. Liver Transpl 10, S23-30.
20. McDiarmid SV, Anand R, Lindblad AS (2002) Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 74, 173-181.
21. Bourdeaux C, Tri TT, Gras J et al. (2005) PELD score and posttransplant outcome in pediatric liver transplantation: a retrospective study of 100 recipients. Transplantation 79, 1273-1276.
22. Lee WM (1997) Acute Liver Failure. Cambridge: Cambridge University Press.
23. O'Grady JG (2005) Acute liver failure. Postgrad Med J 81, 148-154.
24. Dickson ER, Grambsch PM, Fleming TR et al. (1989) Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 10, 1-7.
25. Liermann Garcia RF, Evangelista Garcia C, McMaster P et al. (2001) Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology 33, 22-27.
26. Lee YM, Kaplan MM (1995) Primary sclerosing cholangitis. N Engl J Med 332, 924-933.
27. Dickson ER, Murtaugh PA, Wiesner RH et al. (1992) Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 103, 1893-1901.
28. Kornfeld D, Ekbom A, Ihre T (1997) Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study. Scand J Gastroenterol 32, 1042-1045.
29. Goss JA, Shackleton CR, Farmer DG et al. (1997) Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 225, 472-481; discussion 481-483.
30. Loftus EV, Jr, Aguilar HI, Sandborn WJ et al. (1998) Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 27, 685-690.
31. Mendes FD, Lindor KD (2004) Primary sclerosing cholangitis. Clin Liver Dis 8, 195-211.
32. Graziadei IW, Wiesner RH, Marotta PJ et al. (1999) Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 30, 1121-1127.
33. Graziadei IW, Wiesner RH, Batts KP et al. (1999) Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 29, 1050-1056.
34. Czaja AJ (2002) Treatment strategies in autoimmune hepatitis. Clin Liver Dis 6, 799-824.
35. Gonzalez-Koch A, Czaja AJ, Carpenter HA et al. (2001) Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl 7, 302-310.
36. Everson G, Bharadhwaj G, House R et al. (1997) Long-term followup of patients with alcoholic liver disease who underwent hepatic transplantation. Liver Transpl Surg 3, 263-274.
37. Beresford TP, Everson GT (2000) Liver transplantation for alcoholic liver disease: bias, beliefs, 6-month rule, and relapse-but where are the data? Liver Transpl 6, 777-778.
38. Bravata DM, Olkin I, Barnato AE et al. (2001) Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review. Liver Transpl 7, 191-203.
39. Veldt BJ, Laine F, Guillygomarc'h A et al. (2002) Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol 36, 93-98.
40. Farges O, Saliba F, Farhamant H et al. (1996) Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology 23, 240-248.
41. Bathgate AJ, Hynd P, Sommerville D et al. (1999) The prediction of acute cellular rejection in orthotopic liver transplantation. Liver Transpl Surg 5, 475-479.
42. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362, 1907-1917.
43. El-Serag HB (2004) Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127, S27-34.
44. Wall WJ (2000) Liver transplantation for hepatic and biliary malignancy. Semin Liver Dis 20, 425-436.
45. Everson GT (2000) Increasing incidence and pretransplantation screening of hepatocellular carcinoma. Liver Transpl 6, S2-10.
46. Mazzaferro V, Regalia E, Doci R et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334, 693-699.
47. Sharma P, Balan V, Hernandez JL et al. (2004) Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 10, 36-41.
48. Yoo HY, Patt CH, Geschwind JF et al. (2003) The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 21, 4329-4335.
49. Wiesner RH, Freeman RB, Mulligan DC (2004) Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 127, S261-267.
50. El-Serag HB, Davila JA (2004) Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 39, 798-803.
51. Katzenstein HM, Krailo MD, Malogolowkin MH et al. (2003) Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 97, 2006-2012.
52. Meyer CG, Penn I, James L (2000) Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69, 1633-1637.
53. De Vreede I, Steers JL, Burch PA et al. (2000) Prolonged diseasefree survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 6, 309-316.
54. Lehnert T (1998) Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation 66, 1307-1312.
55. Sutcliffe R, Maguire D, Ramage J et al. (2004) Management of neuroendocrine liver metastases. Am J Surg 187, 39-46.
56. Crawford DH, Fletcher LM, Hubscher SG et al. (2004) Patient and graft survival after liver transplantation for hereditary hemochromatosis: implications for pathogenesis. Hepatology 39, 1655-1662.
57. Brandhagen DJ, Alvarez W, Therneau TM et al. (2000) Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation. Hepatology 31, 456-460.
58. Bowlus CL, Willner I, Zern MA et al. (2005) Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency. Clin Gastroenterol Hepatol 3, 390-396.
59. Putnam CW, Porter KA, Peters RL et al. (1977) Liver replacement for alpha1-antitrypsin deficiency. Surgery 81, 258-261.
60. Elzouki AN, Lindgren S, Nilsson S et al. (1997) Severe alpha1- antitrypsin deficiency (PiZ homozygosity) with membranoproliferative glomerulonephritis and nephrotic syndrome, reversible after orthotopic liver transplantation. J Hepatol 26, 1403-1407.
61. Acharya J, Westwood NB, Sawyer BM et al. (1995) Identification of latent myeloproliferative disease in patients with Budd-Chiari syndrome using X-chromosome inactivation patterns and in vitro erythroid colony formation. Eur J Haematol 55, 315-321.
62. Deltenre P, Denninger MH, Hillaire S et al. (2001) Factor V Leiden related Budd-Chiari syndrome. Gut 48, 264-268.
63. Bismuth H, Sherlock DJ (1991) Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome. Ann Surg 214, 581-589.
64. Shaked A, Goldstein RM, Klintmalm GB et al. (1992) Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet 174, 453-459.
65. Molmenti EP, Segev DL, Arepally A et al. (2005) The utility of TIPS in the management of Budd-Chiari syndrome. Ann Surg 241, 978-981; discussion 982-983.
66. Ochs A (2005) Transjugular intrahepatic portosystemic shunt. Dig Dis 23, 56-64.
67. Pirenne J, Aerts R, Yoong K et al. (2001) Liver transplantation for polycystic liver disease. Liver Transpl 7, 238-245.
68. Everson GT, Taylor MR, Doctor RB (2004) Polycystic disease of the liver. Hepatology 40, 774-782.
69. Zetterman RK, Belle SH, Hoofnagle JH et al. (1998) Age and liver transplantation: a report of the Liver Transplantation Database. Transplantation 66, 500-506.
70. Herrero JI, Lucena JF, Quiroga J et al. (2003) Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant 3, 1407-1412.
71. Carey WD, Dumot JA, Pimentel RR et al. (1995) The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 59, 859-864.
72. Morris JJ, Hellman CL, Gawey BJ et al. (1995) Case 3-1995. Three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation. J Cardiothorac Vasc Anesth 9, 322-332.
73. Donovan CL, Marcovitz PA, Punch JD et al. (1996) Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 61, 1180-1188.
74. Krowka MJ, Cortese DA (1994) Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 105, 1528-1537.
75. Schenk P, Schoniger-Hekele M, Fuhrmann V et al. (2003) Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 125, 1042-1052.
76. Abrams GA, Nanda NC, Dubovsky EV et al. (1998) Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 114, 305-310.
77. Arguedas MR, Abrams GA, Krowka MJ et al. (2003) Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 37, 192-197.
78. Krowka MJ, Porayko MK, Plevak DJ et al. (1997) Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc 72, 44-53.
79. Kuo PC, Plotkin JS, Gaine S et al. (1999) Portopulmonary hypertension and the liver transplant candidate. Transplantation 67, 1087-1093.
80. Castro M, Krowka MJ, Schroeder DR et al. (1996) Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc 71, 543-551.
81. Ramsay MA, Simpson BR, Nguyen AT et al. (1997) Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 3, 494-500.
82. Plotkin JS, Kuo PC, Rubin LJ et al. (1998) Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation 65, 457-459.
83. Ramsay MA, Spikes C, East CA et al. (1999) The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol. Anesthesiology 90, 299-301.
84. Mair P, Kaehler CH, Pomaroli A et al. (2001) Orthotopic liver transplantation in a patient with severe portopulmonary hypertension. Acta Anaesthesiol Scand 45, 513-518.
85. Chua R, Keogh A, Miyashita M (2005) Novel use of sildenafil in the treatment of portopulmonary hypertension. J Heart Lung Transplant 24, 498-500.
86. Makisalo H, Koivusalo A, Vakkuri A et al. (2004) Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation. Liver Transpl 10, 945-950.
87. Prachalias AA, Pozniak A, Taylor C et al. (2001) Liver transplantation in adults coinfected with HIV. Transplantation 72, 1684-1688.
88. Neff GW, Bonham A, Tzakis AG et al. (2003) Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 9, 239-247.
89. Stock PG, Roland ME, Carlson L et al. (2003) Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 76, 370-375.
90. Roland ME, Stock PG (2003) Review of solid-organ transplantation in HIV-infected patients. Transplantation 75, 425-429.
91. Brown RS, Jr, Lombardero M, Lake JR (1996) Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 62, 1788-1793.
92. Nair S, Verma S, Thuluvath PJ (2002) Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35, 1179-1185.
93. Davis CL, Gonwa TA, Wilkinson AH (2002) Identification of patients best suited for combined liver-kidney transplantation: part II. Liver Transpl 8, 193-211.
94. McCauley J, Van Thiel DH, Starzl TE et al. (1990) Acute and chronic renal failure in liver transplantation. Nephron 55, 121-128.
95. Arroyo V, Gines P, Navasa M et al. (1993) Renal failure in cirrhosis and liver transplantation. Transplant Proc 25, 1734-1739.
96. Shields PL, Tang H, Neuberger JM et al. (1999) Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation 68, 530-535.
97. John PR, Thuluvath PJ (2001) Outcome of liver transplantation in patients with diabetes mellitus: a case-control study. Hepatology 34, 889-895.
98. Trotter JF, Bak TE, Wachs ME et al. (2000) Combined liver-pancreas transplantation in a patient with primary sclerosing cholangitis and insulin-dependent diabetes mellitus. Transplantation 70, 1469-1471.
99. Nair S, Verma S, Thuluvath PJ (2002) Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 35, 105-109.
100. Ehlers SL, Rodrigue JR, Widows MR et al. (2004) Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and research. Liver Transpl 10, 412-417.
101. Pungpapong S, Manzarbeitia C, Ortiz J et al. (2002) Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation. Liver Transpl 8, 582-587.
102. Yerdel MA, Gunson B, Mirza D et al. (2000) Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 69, 1873-1881.
103. Forman LM, Lewis JD, Berlin JA et al. (2002) The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 122, 889-896.
104. Charlton M, Seaberg E, Wiesner R et al. (1998) Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 28, 823-830.
105. Forman LM (2003) To transplant or not to transplant recurrent hepatitis C and liver failure. Clin Liver Dis 7, 615-629.
106. Marcos A, Ham JM, Fisher RA et al. (2000) Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 6, 296-301.
107. Bak T, Wachs M, Trotter J et al. (2001) Adult-to-adult living donor liver transplantation using right-lobe grafts: results and lessons learned from a single-center experience. Liver Transpl 7, 680-686.
108. Abecassis M, Adams M, Adams P et al. (2000) Consensus statement on the live organ donor. JAMA 284, 2919-2926.
109. American Society of Transplant Surgeons (2000) Position paper on adult-to-adult living donor liver transplantation. Liver Transpl 6, 815-817.
110. Schiano TD, Kim-Schluger L, Gondolesi G et al. (2001) Adult living donor liver transplantation: the hepatologist's perspective. Hepatology 33, 3-9.
111. Wachs ME, Bak TE, Karrer FM et al. (1998) Adult living donor liver transplantation using a right hepatic lobe. Transplantation 66, 1313-1316.
112. Abt PL, Mange KC, Olthoff KM et al. (2004) Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant 4, 1302-1307.
113. Trotter JF (2005) Living donor liver transplantation: is the hype over? J Hepatol 42, 20-25.
114. Marcos A (2000) Right-lobe living donor liver transplantation. Liver Transpl 6, S59-63.
115. Broelsch CE, Malago M, Testa G et al. (2000) Living donor liver transplantation in adults: outcome in Europe. Liver Transpl 6, S64-65.
116. Todo S, Furukawa H, Jin MB et al. (2000) Living donor liver transplantation in adults: outcome in Japan. Liver Transpl 6, S66-72.
117. Trotter JF, Talamantes M, McClure M et al. (2001) Right hepatic lobe donation for living donor liver transplantation: impact on donor quality of life. Liver Transpl 7, 485-493.
118. Trotter JF, Wachs M, Trouillot T et al. (2000) Evaluation of 100 patients for living donor liver transplantation. Liver Transpl 6, 290-295.
119. Yeh BM, Breiman RS, Taouli B et al. (2004) Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multidetector row CT cholangiography-initial experience. Radiology 230, 645-651.
120. Cheng YF, Chen CL, Huang TL et al. (1999) Magnetic resonance of the hepatic veins with angular reconstruction: application in livingrelated liver transplantation. Transplantation 68, 267-271.
121. Cheng YF, Chen CL, Huang TL et al. (2001) Single imaging modality evaluation of living donors in liver transplantation: magnetic resonance imaging. Transplantation 72, 1527-1533.
122. White SA, Al-Mukhtar A, Lodge JP et al. (2004) Progress in living donor liver transplantation. Transplant Proc 36, 2720-2726.
123. Baltz AC, Trotter JF (2003) Living donor liver transplantation and hepatitis C. Clin Liver Dis 7, 651-665, viii.
124. Garcia-Retortillo M, Forns X, Llovet JM et al. (2004) Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 40, 699-707.
125. Gaglio PJ, Malireddy S, Levitt BS et al. (2003) Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl 9, 1028-1035.
126. Rodriguez-Luna H, Vargas HE, Sharma P et al. (2004) Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci 49, 38-41.
127. Van Vlierberghe H, Troisi R, Colle I et al. (2004) Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults. Transplantation 77, 210-214.
128. Everson GT, Trotter J, Forman L et al. (2005) Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 42, 255-262.